Skip to main content
Fig. 2 | BMC Research Notes

Fig. 2

From: Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan

Fig. 2

Changes in the number of drugs and daily drug costs and top 10 drugs whose frequency of use changed significantly before and after hospitalization. Changes in the number of drugs since admission were increased (6 patients, 11%), unchanged (n = 15, 28%), decreased by 1 drug (n = 4, 8%), decreased by 2 drugs (n = 3, 6%), decreased by more than 2 drugs (n = 25, 47%). Daily drug costs were significantly reduced when comparing hospital admission and discharge (hospitalization vs. discharge: 8.3 vs. 6.1, P < 0.001, 1$ = 100 yen, Wilcoxon signed rank test). ACE-I Angiotensin-converting-enzyme inhibitor, ARB Angiotensin II receptor blocker, BZP Benzodiazepine, CCB Calcium channel blocker, NSAIDs Non-Steroidal Anti-Inflammatory Drugs, PPI Proton pump inhibitor

Back to article page